{
    "Labels": {
        "Journal": "Diabetes Obes Metab .",
        "PublicationYear": "2010",
        "Title": "Comparison between a basal - bolus and a premixed insulin regimen in individuals with type 2 diabetes - results of the GINGER study .",
        "Author": "Fritsche A",
        "ObjectiveDescription": "using premixed insulin ( premix ) twice daily .",
        "Frequency": "twice daily",
        "NumberPatientsCT": "310",
        "NumberPatientsArm": "153",
        "Precondition": "subjects with type 2 diabetes ( T2D ) on premix , with or without metformin",
        "SdDevBL": "0 . 8",
        "AvgAge": "60 . 2 + / - 7 . 5 years",
        "DiffGroupAbsValue": "- 0 . 476",
        "PvalueDiff": "p = 0 . 0001",
        "ConfIntervalDiff": "95 % Cl : - 0 . 714 , - 0 . 238",
        "PercentageAffected": "46 . 6",
        "NumberAffected": "43",
        "SdDevChangeValue": "2 . 3",
        "SubGroupDescription": "postprandial",
        "TimePoint": "Endpoint",
        "ResultMeasuredValue": "98 . 0",
        "SdDevResValue": "44 . 3",
        "ConclusionComment": "An intensified basal - bolus regimen using glargine / glulisine results in a significantly superior glycaemic control vs . premix therapy in a population with long - standing insulin - treated T2D , with no increase in the rates of hypoglycaemia .",
        "PMID": "20092584",
        "AllocationRatio": "1 : 1",
        "DoseValue": "300",
        "ObservedResult": "reduced",
        "MinAge": "19",
        "PValueChangeValue": "P < 0 . 05",
        "ConfIntervalChangeValue": "95 % CI - 0 . 82 , 0 . 04",
        "CTDesign": "non - inferiority",
        "DoseDescription": "Doses of each medication were adjusted on the basis of the glycaemic response .",
        "Country": "New Zealand",
        "AggregationMethod": "hazard ratio",
        "RelativeChangeValue": "35",
        "FinalNumPatientsArm": "137",
        "Drug": "benfluorex"
    }
}